Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 120Leukemia, Myeloid, Acute 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Hodgkin Disease 70Leukemia 67Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Non-Hodgkin 63Multiple Myeloma 59Myeloproliferative Disorders 57Lymphoma 54Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Leukemia, Myeloid, Accelerated Phase 46Lymphoma, Follicular 44Leukemia, Myelomonocytic, Chronic 44Leukemia, Myeloid, Chronic-Phase 44Congenital Abnormalities 43Lymphoma, Mantle-Cell 42Primary Myelofibrosis 41Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 39Burkitt Lymphoma 36Blast Crisis 36Graft vs Host Disease 35Neoplasms, Plasma Cell 34Lymphoma, Large-Cell, Immunoblastic 32Myelodysplastic-Myeloproliferative Diseases 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Waldenstrom Macroglobulinemia 21Lymphoma, T-Cell, Cutaneous 20Anemia, Refractory, with Excess of Blasts 20

Interventions

venetoclax 1thymoglobulin 1tagraxofusp 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Tacrolimus × Myeloid × Clear all
NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡